Characterizing Pharmacokinetics in Children With Obesity—Physiological, Drug, Patient, and Methodological ConsiderationsJacqueline G. Gerhart, Daniel González, Stephen J. Balevic et al.|Frontiers in Pharmacology|2022Cited by 40
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic ModelingJacqueline G. Gerhart, Robert H. Lurie, Christoph P. Hornik et al.|Clinical Pharmacokinetics|2021Cited by 39
Use of <scp>physiologically‐based</scp> pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesityJacqueline G. Gerhart, Daniel González, Fernando Carreño et al.|CPT Pharmacometrics & Systems Pharmacology|2022Cited by 14
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D. Maglalang, Lauri Filar, Jaydeep Sinha et al.|Clinical Pharmacokinetics|2024Cited by 5
Racial and Ethnic Differences Associated With Feeding- and Activity-Related Behaviors in InfantsAsheley Cockrell Skinner, Ayumi Shintani, Svetlana Eden et al.|Carolina Digital Repository (University of North Carolina at Chapel Hill)|2021Cited by 0